{"organizations": [], "uuid": "5cac2d627516d1b3d72aafe6b6c24332957ba829", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180515.html", "section_title": "Archive News &amp; Video for Tuesday, 15 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-intec-pharma-to-voluntarily-delist/brief-intec-pharma-to-voluntarily-delist-from-trading-on-the-tel-aviv-stock-exchange-idUSFWN1SM1FS", "country": "US", "domain_rank": 408, "title": "BRIEF-Intec Pharma To Voluntarily Delist From Trading On The Tel Aviv Stock Exchange", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.041, "site_type": "news", "published": "2018-05-16T06:40:00.000+03:00", "replies_count": 0, "uuid": "5cac2d627516d1b3d72aafe6b6c24332957ba829"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-intec-pharma-to-voluntarily-delist/brief-intec-pharma-to-voluntarily-delist-from-trading-on-the-tel-aviv-stock-exchange-idUSFWN1SM1FS", "ord_in_thread": 0, "title": "BRIEF-Intec Pharma To Voluntarily Delist From Trading On The Tel Aviv Stock Exchange", "locations": [], "entities": {"persons": [], "locations": [{"name": "israel", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "tel aviv stock exchange", "sentiment": "negative"}, {"name": "intec pharma ltd", "sentiment": "negative"}, {"name": "intec pharma", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "united states", "sentiment": "none"}, {"name": "thomson reuters trust principles", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 15 (Reuters) - Intec Pharma Ltd:\n* INTEC PHARMA SAYS BOARD DECIDED TO TAKE STEPS TO VOLUNTARILY DELIST CO’S ORDINARY SHARES FROM TRADING ON THE TEL AVIV STOCK EXCHANGE LTD - SEC FILING\n* FOLLOWING DELISTING IN ISRAEL, CO’S ORDINARY SHARES WILL CONTINUE TO TRADE ON THE NASDAQ CAPITAL MARKET IN THE UNITED STATES Source text :( bit.ly/2rERYRV ) Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles. ", "external_links": ["https://twitter.com/reuters", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "https://instagram.com/reuters/", "https://www.youtube.com/user/ReutersVideo", "https://bit.ly/2rERYRV"], "published": "2018-05-16T06:40:00.000+03:00", "crawled": "2018-05-16T19:21:51.013+03:00", "highlightTitle": ""}